Physician profile
Haroon Sarwar
NPI 1639188949
$15,203.17
in general payments reported to CMS, 2019-2025
17 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,305 · 2021: $121 · 2022: $188 · 2023: $96.17 · 2024: $58.15 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.70 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $10,070.23 | 2019 | |
| Amgen INC. | $4,386.45 | 2020-2025 | Tavneos, Otezla, Enbrel |
| Abbvie INC. | $158.05 | 2020-2025 | Rinvoq, Humira |
| Ironwood Pharmaceuticals, INC | $144.35 | 2022 | |
| Genentech USA, INC. | $112.54 | 2019 | |
| Novartis Pharmaceuticals Corporation | $96.48 | 2021-2025 | |
| Pfizer INC. | $54.87 | 2019-2025 | |
| Horizon Therapeutics Plc | $38.32 | 2021-2023 | Krystexxa |
| Bioventus LLC | $22.76 | 2020 | |
| Ani Pharmaceuticals, INC. | $20.65 | 2025 | Purified Cortrophin Gel |
| Exact Sciences Corporation | $19.57 | 2023 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $18.26 | 2024 | Tremfya |
| Alexion Pharmaceuticals, INC. | $17.55 | 2025 | Strensiq |
| Depuy Synthes Sales INC. | $15.91 | 2020 | |
| Nestle Healthcare Nutrition INC. | $13.78 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.40 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haroon Sarwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.